Covens A - Search Results

1

A comparison of the toxicity and tolerability of two intraperitoneal chemotherapy regimens for advanced-stage epithelial ovarian cancer.

Bouchard-Fortier G, Rosen B, Vyarvelska I, Pasetka M, Covens A, Gien LT, Kupets R, Pulman K, Ferguson SE, Vicus D. Bouchard-Fortier G, et al. Among authors: covens a. Gynecol Oncol. 2016 Jan;140(1):36-41. doi: 10.1016/j.ygyno.2015.11.005. Epub 2015 Nov 4. Gynecol Oncol. 2016. PMID: 26546964

2

Intraperitoneal therapy of malignant ascites associated with carcinoma of ovary and breast using radioiodinated monoclonal antibody 2G3.

Buckman R, De Angelis C, Shaw P, Covens A, Osborne R, Kerr I, Reed R, Michaels H, Woo M, Reilly R, et al. Buckman R, et al. Among authors: covens a. Gynecol Oncol. 1992 Oct;47(1):102-9. doi: 10.1016/0090-8258(92)90084-v. Gynecol Oncol. 1992. PMID: 1427388 Clinical Trial.

3

Phase II study of mitomycin C and 5 fluorouracil in platinum resistant ovarian cancer.

Covens A, O'Connell G, Rusthoven J, Mazurka J. Covens A, et al. Eur J Gynaecol Oncol. 1992;13(2):125-30. Eur J Gynaecol Oncol. 1992. PMID: 1587289

4

The prognostic importance of site and type of radiation-induced bowel injury in patients requiring surgical management.

Covens A, Thomas G, DePetrillo A, Jamieson C, Myhr T. Covens A, et al. Gynecol Oncol. 1991 Dec;43(3):270-4. doi: 10.1016/0090-8258(91)90034-3. Gynecol Oncol. 1991. PMID: 1752499

5

High-dose methotrexate for gestational trophoblastic disease.

Elit L, Covens A, Osborne R, Gerulath A, Murphy J, Rosen B, Sturgeon J. Elit L, et al. Among authors: covens a. Gynecol Oncol. 1994 Sep;54(3):282-7. doi: 10.1006/gyno.1994.1211. Gynecol Oncol. 1994. PMID: 7522198 Clinical Trial.

6

Does aggressive therapy improve survival in suboptimal stage IIIc/IV ovarian cancer? A Canadian-American comparative study.

LoCoco S, Covens A, Carney M, Franssen E, Dogde R, Rosen B, Osborne R, Kerr I, Buckman R, Soper J, et al. LoCoco S, et al. Among authors: covens a. Gynecol Oncol. 1995 Nov;59(2):194-9. doi: 10.1006/gyno.1995.0007. Gynecol Oncol. 1995. PMID: 7590472

7

Differences in the morbidity of radical hysterectomy between gynecological oncologists.

Covens A, Rosen B, Gibbons A, Osborne R, Murphy J, DePetrillo A, Lickrish G, Shaw P, Colgan T. Covens A, et al. Gynecol Oncol. 1993 Oct;51(1):39-45. doi: 10.1006/gyno.1993.1243. Gynecol Oncol. 1993. PMID: 8244172

8

Is paclitaxel and cisplatin a cost-effective first-line therapy for advance ovarian carcinoma?

Covens A, Boucher S, Roche K, Macdonald M, Pettitt D, Jolain B, Souetre E, Rivière M. Covens A, et al. Cancer. 1996 May 15;77(10):2086-91. doi: 10.1002/(SICI)1097-0142(19960515)77:10<2086::AID-CNCR18>3.0.CO;2-R. Cancer. 1996. PMID: 8640674

9

A phase II study of leuprolide in advanced/recurrent endometrial cancer.

Covens A, Thomas G, Shaw P, Ackerman I, Osborne R, Lukka H, Carey M, Franssen E, Roche K. Covens A, et al. Gynecol Oncol. 1997 Jan;64(1):126-9. doi: 10.1006/gyno.1996.4544. Gynecol Oncol. 1997. PMID: 8995560 Clinical Trial.

10

Gynecologists' perspectives regarding ovarian cancer.

Fitch MI, Gray RE, Covens A, Thomas G, Franssen E, DePetrillo D, Rosen B. Fitch MI, et al. Among authors: covens a. Cancer Prev Control. 1999 Feb;3(1):68-76. Cancer Prev Control. 1999. PMID: 10474755

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters